INVESTOR ALERT: Investigation of Myriad Genetics, Inc. (MYGN) Announced by Holzer & Holzer, LLC
1. Holzer & Holzer investigates Myriad Genetics for securities law compliance issues. 2. Myriad lowered 2025 financial guidance due to 20% revenue decline. 3. The stock price dropped following the announcement of the financial results. 4. Legal representation offered to investors who lost money on Myriad stock.